Tech Company Financing Transactions

Tetra Discovery Partners Funding Round

Grand Angels, Biosciences Research and Commercialization Center and Invest Michigan participated in a $1 million capital raise for Tetra Discovery Partners. This venture round was announced on 9/3/2015.

Transaction Overview

Announced On
9/3/2015
Transaction Type
Venture Equity
Amount
$1,000,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to accelerate development as it prepares for clinical trials in Fall 2015.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
38 Fulton St. W 303
Grand Rapids, MI 49503
USA
Email Address
Overview
Our research focuses on developing new treatments for depression based on subtype-selective modulation of phosphodiesterase 4B (PDE4B). PDE4 in neurons is responsible for the hydrolysis of cAMP. We and our colleagues recently described the protein structure of a key PDE4 regulatory domain known as UCR2.
Profile
Tetra Discovery Partners LinkedIn Company Profile
Social Media
Tetra Discovery Partners Company Twitter Account
Company News
Tetra Discovery Partners News
Facebook
Tetra Discovery Partners on Facebook
YouTube
Tetra Discovery Partners on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Mark Gurney
  Mark Gurney LinkedIn Profile  Mark Gurney Twitter Account  Mark Gurney News  Mark Gurney on Facebook
Chief Financial Officer
Harvey Elgersma
  Harvey Elgersma LinkedIn Profile  Harvey Elgersma Twitter Account  Harvey Elgersma News  Harvey Elgersma on Facebook
Chief Medical Officer
Scott Reines
  Scott Reines LinkedIn Profile  Scott Reines Twitter Account  Scott Reines News  Scott Reines on Facebook
VP - Bus. Development
Joseph Collard
  Joseph Collard LinkedIn Profile  Joseph Collard Twitter Account  Joseph Collard News  Joseph Collard on Facebook
VP - Regulatory Affairs
Chad Coberly
  Chad Coberly LinkedIn Profile  Chad Coberly Twitter Account  Chad Coberly News  Chad Coberly on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/3/2015: Tragara Pharmaceuticals venture capital transaction
Next: 9/3/2015: Saucey venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to document tech company VC transactions. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary